Mind Share Partners is a US-based nonprofit organization focused on changing the culture of workplace mental health so that employees and organizations can thrive. It helps employers create mentally healthy workplaces through consulting and training, and is building a national movement to change the landscape around work.
Sherry A. Southerland and Jennifer Schellinger tell us what we need to know about Learning Through Collaborative Design-Professional Development (LCD PD) in this special science education focus.
Professor Paramala Santosh, CEO of HealthTracker Ltd, co-developed the HealthTrackerTM platform – developed by clinicians, assisted by patients for patients, clinicians & researchers, more of which we learn about here.
When it comes to talking about anti-Asian racism and recent violence with pupils, teachers may feel unsure of how to start - here, University of Kansas researchers explain how popular culture can help.
We spoke with Dr Matthew Duchars, CEO of the UK’s first dedicated Vaccines Manufacturing and Innovation Centre (VMIC), about their work not only to provide an integral response to COVID-19, but as a centre of excellence advancing the vaccine sector on a global scale.
A "human error" created a factory mixup for Johnson & Johnson in Baltimore, Maryland, damaging up to 15 million vaccine doses - but this does not impact doses that are ready for use.
Open Access Government charts the recent policy priorities of Virginijus Sinkevičius, the European Commissioner for the Environment, Oceans and Fisheries, as Europe works towards a circular economy.
Mark Griffin, Hydrogen Market Development Manager for Clean Fuels, BOC, explains how to deploy hydrogen transport infrastructure to meet net-zero in this guide for councils.
Jarek Salek, Head of Engineering and Technical Operations at Uvisan, explains how UV-C cleaning in educational facilities can make shared equipment safe from COVID and help resume teaching that involves computers and other shared hardware.
Dave Sherwood, CEO and Founder at BibliU, explores the ways in which universities can improve student accessibility for those with a range of abilities and backgrounds.
Real-world use of the Moderna and Pfizer vaccines in the United States reveals that both are working at 90% efficacy - with data pointing to one dose being capable of 80% protection.
